• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic drug approvals, December 2008

Article

Generic drugs approved by FDA (through December 2008) including levetiracetam tablets, dorzolamide/timolol ophthalmic solution, and dorzolamide ophthalmic solution

Levetiracetam tablets, 250, 500, and 750 mg (equiv to Keppra tablets)
MYLAN

Dorzolamide/timolol ophthalmic solution, 2% (base)/0.5% (base) (equiv to Cosopt Ophthalmic Solution)
APOTEX, HI-TECH

Dorzolamide ophthalmic solution, 2% (base) (equiv to Trusopt Ophthalmic Solution)
APOTEX, HI-TECH

© 2024 MJH Life Sciences

All rights reserved.